Monitoring humans for somatic mutation in the endogenous pig-a gene using red blood cells

Environmental and Molecular Mutagenesis

Volumn 52, Issue 9, 2011, Pages 784-794

  Dobrovolsky, Vasily N ^a   Elespuru, Rosalie K ^b   Bigger, C Anita H ^c   Robison, Timothy W ^c   Heflich, Robert H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

CD59 surface marker; Chemotherapy; Clastogen; Flow cytometry; Glycophorin; Glycosyl phosphatidyl inositol anchor

Indexed keywords

CD59 ANTIGEN; CISPLATIN; ETOPOSIDE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CELL ASSAY; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; MALE; MUTANT; NORMAL HUMAN; SOMATIC MUTATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD59; ANTINEOPLASTIC AGENTS; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; GENETIC TESTING; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTAGENS; MUTATION; YOUNG ADULT;

ANIMALIA; MAMMALIA; RODENTIA; SUIDAE;

EID: 80155153730     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20667     Document Type: Article

References (35)

1. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. 1999. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 96: 5209-5214.
2. Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda J, Luzzatto L, Kinoshita T. 1994. Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 13: 110-117.
3. Branda RF, Sullivan LM, O'Neill JP, Falta MT, Nicklas JA, Hirsch B, Vacek PM, Albertini RJ. 1993. Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat Res 285: 267-279.
4. Brodsky RA, Hu R. 2006. PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis. Leuk Lymphoma 47: 1215-1221.
5. Brodsky RA, Mukhina GL, Nelson KL, Lawrence TS, Jones RJ, Buckley JT. 1999. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood 93: 1749-1756.
6. Brodsky RA, Mukhina GL, Li S, Nelson KL, Chiurazzi PL, Buckley JT, Borowitz MJ. 2000. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 114: 459-466.
7. Bryce SM, Bemis JC, Dertinger SD. 2008. In vivo mutation assay based on the endogenous Pig-A locus. Environ Mol Mutagen 49: 256-264.
8. Dertinger SD, Phonethepswath S, Franklin D, Weller P, Torous DK, Bryce SM, Avlasevich S, Bemis JC, Hyrien O, Palis J, Macgregor JT. 2010. Integration of mutation and chromosomal damage endpoints into 28-day repeat dose toxicology studies. Toxicol Sci 115: 401-411.
9. Dertinger SD, Bryce SM, Phonethepswath S, Avlasevich SL. 2011. When pigs fly: Immunomagnetic separation facilitates rapid determination of Pig-A mutant frequency by flow cytometric analysis. Mutat Res 721:163-170.
10. Dobrovolsky VN, Shaddock JG, Mittelstaedt RA, Manjanatha MG, Miura D, Uchikawa M, Mattison DR, Morris SM. 2009. Evaluation of Macaca mulatta as a model for genotoxicity studies. Mutat Res 673: 21-28.
11. Dobrovolsky VN, Miura D, Heflich RH, Dertinger SD. 2010a. The in vivo Pig-A gene mutation assay, a potential tool for regulatory safety assessment. Environ Mol Mutagen 51: 825-835.
12. Dobrovolsky VN, Boctor SY, Twaddle NC, Doerge DR, Bishop ME, Manjanatha MG, Kimoto T, Miura D, Heflich RH, Ferguson SA. 2010b. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: Application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats. Environ Mol Mutagen 51: 138-145.
13. Donev RM, Sivasankar B, Mizuno M, Morgan BP. 2008. The mouse complement regulator CD59b is significantly expressed only in testis and plays roles in sperm acrosome activation and motility. Mol Immunol 45: 534-542.
14. Dong Q, Barsky D, Colvin ME, Melius CF, Ludeman SM, Moravek JF, Colvin OM, Bigner DD, Modrich P, Friedman HS. 1995. A structural basis for a phosphoramide mustard-induced DNA interstrand cross-link at 5′-D(GAC). Proc Natl Acad Sci USA 92: 12170-12174.
15. Hall SE, Rosse WF. 1996. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 87: 5332-5340.
16. Hatanaka M, Inai S, Matsumoto M, Miyagawa S, Masaoka T, Kanamaru A, Kawakita M, Yonemura Y, Sugita Y, Seya T. 1993. Implication of membrane factors other than DAF and CD59 in complement-mediated lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Clin Immunol Immunopathol 69: 52-59.
17. Hernandez-Campo PM, Almeida J, Sanchez ML, Malvezzi M, Orfao A. 2006. Normal patterns of expression of glycosylphosphatidylinositol-anchored proteins on different subsets of peripheral blood cells: A frame of reference for the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry B Clin Cytom 70: 71-81.
18. Hinz JM. 2010. Role of homologous recombination in DNA interstrand crosslink repair. Environ Mol Mutagen 51: 582-603.
19. Hu R, Mukhina GL, Piantadosi S, Barber JP, Jones RJ, Brodsky RA. 2005. PIG-A mutations in normal hematopoiesis. Blood 105: 3848-3854.
20. Kinoshita T, Fujita M, Maeda Y. 2008. Biosynthesis, remodelling and functions of mammalian GPI-anchored proteins: Recent progress. J Biochem 144: 287-294.
21. Long BH, Fairchild CR. 1994. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase. Cancer Res 54: 4355-4361.
22. Miura D, Dobrovolsky VN, Kasahara Y, Katsuura Y, Heflich RH. 2008. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat. Environ Mol Mutagen 49: 614-621.
23. Miura D, Dobrovolsky VN, Kimoto T, Kasahara Y, Heflich RH. 2009. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea. Mutat Res 677: 86-92.
24. Mortazavi Y, Merk B, Mcintosh J, Marsh JC, Schrezenmeier H, Rutherford TR. 2003. The spectrum of PIG-A gene mutations in aplastic anemia/paroxysmal nocturnal hemoglobinuria (AA/PNH): A high incidence of multiple mutations and evidence of a mutational hot spot. Blood 101: 2833-2841.
25. Nafa K, Bessler M, Castro-Malaspina H, Jhanwar S, Luzzatto L. 1998. The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis 24: 370-384.
26. Nishimura J, Murakami Y, Kinoshita T. 1999. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease. Am J Hematol 62: 175-182.
27. Peruzzi B, Araten DJ, Notaro R, Luzzatto L. 2010. The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo. Mutat Res 705: 3-10.
28. Phonethepswath S, Bryce SM, Bemis JC, Dertinger SD. 2008. Erythrocyte-based Pig-A gene mutation assay: Demonstration of cross-species potential. Mutat Res 657: 122-126.
29. Phonethepswath S, Franklin D, Torous DK, Bryce SM, Bemis JC, Raja S, Avlasevich S, Weller P, Hyrien O, Palis J, Macgregor JT, Dertinger SD. 2010. Pig-A mutation: Kinetics in rat erythrocytes following exposure to five prototypical mutagens. Toxicol Sci 114: 59-70.
30. Qin X, Miwa T, Aktas H, Gao M, Lee C, Qian YM, Morton CC, Shahsafaei A, Song WC, Halperin JA. 2001. Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm Genome 12: 582-589.
31. Sampath D, Rao VA, Plunkett W. 2003. Mechanisms of apoptosis induction by nucleoside analogs. Oncogene 22: 9063-9074.
32. Ware RE, Rosse WF, Hall SE. 1995. Immunophenotypic analysis of reticulocytes in paroxysmal nocturnal hemoglobinuria. Blood 86: 1586-1589.
33. Ware RE, Pickens CV, Decastro CM, Howard TA. 2001. Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes. Exp Hematol 29: 1403-1409.
34. Yoon JH, Lee CS. 1997. Sequence specificity for DNA interstrand cross-linking induced by anticancer drug chlorambucil. Arch Pharm Res 20: 550-554.
35. Young NS, Maciejewski JP, Sloand E, Chen G, Zeng W, Risitano A, Miyazato A. 2002. The relationship of aplastic anemia and PNH. Int J Hematol 76 (Suppl 2): 168-172.